|
|
|
Volumn 10, Issue SUPPL. 4, 1995, Pages
|
|
Design and assessment of cost-effectiveness studies in AIDS populations
|
|
Author keywords
AIDS; Cost effectiveness analysis; Cost utility ratio; Economic analysis; Economic clinical trial; HIV; Polypharmacy; Quality adjusted life year
|
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
COTRIMOXAZOLE;
DAPSONE;
DIDANOSINE;
FLUCONAZOLE;
FOSCARNET;
GANCICLOVIR;
ITRACONAZOLE;
PENTAMIDINE;
RIFABUTIN;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC ASPECT;
HEALTH CARE COST;
HUMAN;
MORBIDITY;
MYCOBACTERIOSIS;
MYCOBACTERIUM INTRACELLULARE AVIUM;
OPPORTUNISTIC INFECTION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
STAGING;
SURVIVAL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTIVIRAL AGENTS;
COST-BENEFIT ANALYSIS;
HUMAN;
LIFE EXPECTANCY;
QUALITY OF LIFE;
RESEARCH DESIGN;
MYCOBACTERIUM;
MYCOBACTERIUM AVIUM-INTRACELLULARE;
MYCOBACTERIUM INTRACELLULARE;
PNEUMOCYSTIS CARINII;
|
|
EID: 0028851646
PISSN: 10779450
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
